404 web-programmer-developer-"https:"-"UCL"-"U"-"Bocconi-University"-"https:" positions at Medical College of Wisconsin
Sort by
Refine Your Search
-
contact with study participants. Collect, analyze, and disseminate research data. Report program data and progress to study investigators. Work with Principal Investigator to develop, implement, and
-
primary interest in Benign Hematology. Rank for this position is open. Position Highlights Collaborate with five benign hematologists who have a variety of sub-specializations. Develop and grow through your
-
and timely progress notes, procedure notes, and/or admission and transfer orders. Develop pharmaceutical and non-pharmaceutical treatment plans. Monitor effectiveness of plan of care. Educate patients
-
delivery of additional courses, community engagement, and support for program development and communications. Primary Responsibilities
-
and timely progress notes, procedure notes, and/or admission and transfer orders. Develop pharmaceutical and non-pharmaceutical treatment plans. Monitor effectiveness of plan of care. Educate patients
-
and research. Our academic practice has over 60 cardiologists and has state of the art equipment and new facilities. The comprehensive FMCW cardiac program includes a full complement of complex and
-
including injectables and laser/energy-based devices. Competitive compensation and benefits package with protected academic time and support for research and professional development. Benefits: MCW
-
/BE in Internal Medicine and eligible to be licensed in Wisconsin. Faculty may enroll in our successful career development program. MCW as an Equal Opportunity Employer and Commitment to Non
-
programs. Modify and/or develop computer program based research tests. Other duties as assigned. Knowledge – Skills – Abilities Knowledge of biology, computers, mathematics, documentation, and records
-
will participate in a research program focused on characterizing the role of RNA binding proteins, immuno-oncology research, and antibody development and validation for cancer therapy in the lab of Dr